Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28827713 | 0.97 | HSD17B10 (0.33) | HSD17B10 | |
| SCHEMBL1573497 | 0.77 | ALDH1A1 (0.32) | — | |
| SCHEMBL5874546 | 0.75 | SLC22A1 (0.35) | — | |
| SCHEMBL5874470 | 0.71 | SLC22A1 (0.41) | — | |
| Propane SCHEMBL11244315 | 0.71 | MEN1 (0.33) | — | |
| SCHEMBL9010761 | 0.71 | — | — | |
| SCHEMBL8864202 | 0.71 | — | — | |
| Hydrogen Sulfide SCHEMBL28046696 | 0.70 | — | — | |
| Sulfuric Acid SCHEMBL28167631 | 0.70 | — | — | |
| Sulfuric Acid SCHEMBL9350051 | 0.69 | CA5A (0.43) | HSD17B10CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293782-B2 | Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe | CANON KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | claimed |
| US-20100197937-A1 | NOVEL COMPOUND, PROBE CONTAINING THE NOVEL COMPOUND, AND FLUORESCENCE-IMAGING CONTRAST AGENT CONTAINING THE NOVEL COMPOUND OR THE PROBE | CANON KABUSHIKI KAISHA (JP) | 2010-08-05 | — | — | US | claimed |
| WO-2023123406-A1 | METHOD FOR PREPARING ACESULFAME POTASSIUM | 安徽金禾实业股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| CN-116178315-A | Method for efficiently converting chitosan into 5-hydroxymethylfurfural by using sulfonated ionic liquid | 集美大学 | 2023-05-30 | — | — | CN | disclosed |
| US-8293782-B2 | Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe | CANON KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8293782-B2 | Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe | CANON KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20120016044-A1 | PROCESS TO PREPARE FLUOROPOLYMER DISPERSIONS AND MEMBRANES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-19 | — | — | US | disclosed |
| US-8058319-B2 | Process to prepare fluoropolymer dispersions and membranes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-15 | — | — | US | disclosed |
| EP-2027194-B1 | FLUOROPOLYMER DISPERSIONS | DU PONT (US) | 2011-07-06 | — | — | EP | disclosed |
| EP-2027191-B1 | PROCESS TO PREPARE FLUOROPOLYMER DISPERSIONS AND MEMBRANES | DU PONT (US) | 2011-01-26 | — | — | EP | disclosed |
| JP-2010195764-A | NEW COMPOUND, PROBE USING THE SAME AND CONTRAST MEDIUM FOR FLUORESCENT IMAGING USING THE NEW COMPOUND OR THE PROBE | CANON INC | 2010-09-09 | — | — | JP | disclosed |
| EP-1022289-B1 | NOVEL GLYCOSAMINOGLYCAN AND DRUG COMPOSITIONS CONTAINING THE SAME | SEIKAGAKU KOGYO CO LTD (JP) | 2004-07-07 | — | — | EP | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
| US-6492503-B1 | HAVING BACKBONE STRUCTURE COMPRISING REPETITIVE DISACCHARIDE BEARING A URONIC ACID RESIDUE AND A GLUCOSAMINE RESIDUE, AND HAVING SULFATE GROUPS, WITH SUBSTANTIALLY NO SULFATE GROUP BOUND TO HYDROXYL GROUP AT 6-POSITION OF THE GLUCOSAMINE | SEIKAGAKU CORPORATION (JP) | 2002-12-10 | — | — | US | disclosed |
| EP-0747418-B1 | Aromatic polyimide and gas separation | UBE INDUSTRIES (JP) | 2002-07-03 | — | — | EP | disclosed |
| EP-1022289-A1 | NOVEL GLYCOSAMINOGLYCAN AND DRUG COMPOSITIONS CONTAINING THE SAME | SEIKAGAKU CORPORATION (JP) | 2000-07-26 | — | — | EP | disclosed |
| US-5744575-A | Aromatic polyimide and gas separation | UBE INDUSTRIES, LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
| EP-0747418-A1 | Aromatic polyimide and gas separation | UBE INDUSTRIES, LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
| US-5068226-A | For transdermal delivery of drugs | CYCLEX, INC. (US) | 1991-11-26 | — | — | US | disclosed |
| US-4266048-A | Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1981-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197937-A1 | NOVEL COMPOUND, PROBE CONTAINING THE NOVEL COMPOUND, AND FLUORESCENCE-IMAGING CONTRAST AGENT CONTAINING THE NOVEL COMPOUND OR THE PROBE | RXFP1, ARG1, KCNMB1 | HSD17B10 4348/4885CA5A 2319/4885CA5B 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.